FAS	O
-	O
1377	O
G	O
/	O
A	O
polymorphism	O
and	O
the	O
risk	O
of	O
lymph	B-Multi-tissue_structure
node	I-Multi-tissue_structure
metastasis	O
in	O
cervical	B-Cancer
cancer	I-Cancer
.	O

Single	O
-	O
nucleotide	O
polymorphisms	O
of	O
the	O
FAS	O
-	O
1377G	O
/	O
A	O
,	O
FAS	O
-	O
670A	O
/	O
G	O
,	O
and	O
FASL	O
-	O
844T	O
/	O
C	O
genes	O
may	O
alter	O
transcriptional	O
activity	O
of	O
these	O
genes	O
.	O

Recent	O
evidence	O
suggests	O
an	O
association	O
of	O
these	O
polymorphisms	O
with	O
an	O
increased	O
risk	O
of	O
cervical	B-Cancer
cancer	I-Cancer
,	O
so	O
we	O
explored	O
this	O
relationship	O
.	O

Genotypes	O
of	O
155	O
patients	O
with	O
cervical	B-Cancer
cancer	I-Cancer
and	O
160	O
healthy	O
control	O
subjects	O
were	O
determined	O
using	O
polymerase	O
chain	O
reaction	O
-	O
based	O
restriction	O
fragment	O
length	O
polymorphism	O
(	O
PCR	O
-	O
RFLP	O
)	O
.	O

Associations	O
with	O
cancer	B-Cancer
risk	O
were	O
estimated	O
using	O
two	O
-	O
sided	O
logistic	O
regression	O
.	O

We	O
observed	O
a	O
significantly	O
increased	O
risk	O
of	O
lymph	B-Multi-tissue_structure
node	I-Multi-tissue_structure
metastasis	O
associated	O
with	O
the	O
FAS	O
-	O
1377	O
GA	O
or	O
AA	O
polymorphism	O
[	O
odds	O
ratio	O
(	O
OR	O
)	O
=	O
4	O
.	O
16	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
=	O
1	O
.	O
10	O
to	O
15	O
.	O
74	O
;	O
P	O
=	O
0	O
.	O
036	O
]	O
.	O

In	O
addition	O
,	O
the	O
FAS	O
-	O
670AG	O
or	O
GG	O
genotype	O
showed	O
an	O
increased	O
incidence	O
of	O
node	B-Multi-tissue_structure
metastasis	O
,	O
but	O
these	O
findings	O
were	O
not	O
statistically	O
significant	O
(	O
OR	O
=	O
3	O
.	O
67	O
,	O
95	O
%	O
CI	O
=	O
0	O
.	O
96	O
-	O
14	O
.	O
00	O
,	O
P	O
=	O
0	O
.	O
059	O
)	O
.	O

There	O
was	O
no	O
significant	O
association	O
between	O
an	O
increased	O
risk	O
of	O
cervical	B-Cancer
cancer	I-Cancer
and	O
polymorphisms	O
of	O
the	O
death	O
pathway	O
genes	O
FAS	O
and	O
FASL	O
.	O

None	O
of	O
the	O
polymorphisms	O
were	O
associated	O
with	O
risk	O
of	O
advanced	O
stage	O
or	O
histologic	O
subtype	O
of	O
cervical	B-Cancer
cancer	I-Cancer
.	O

In	O
conclusion	O
,	O
FAS	O
-	O
1377	O
G	O
-	O
-	O
>	O
A	O
polymorphism	O
may	O
be	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
lymph	B-Multi-tissue_structure
node	I-Multi-tissue_structure
metastasis	O
in	O
Korean	O
cervical	B-Cancer
cancer	I-Cancer
patients	O
.	O

